⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
APLS News
Apellis Pharmaceuticals, Inc. Common Stock
Sobi Receives European Commission Approval for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
prnewswire.com
APLS
Peptide Therapeutics Market Report 2025-2035: Industry to Experience Robust Growth with a CAGR of 6.8% Through 2035 - Subcutaneous Route to Command Over 65% Share - ResearchAndMarkets.com
businesswire.com
APLS
BLRX
LLY
NTRA
NVO
PLTK
ZBRA
Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns
globenewswire.com
APLS
BLRX
LLY
NVO
TAK
Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
APLS
The Geographic Atrophy Industry: A Global and Regional Analysis 2025-2035
globenewswire.com
APLS
NVS
Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
APLS
EZLynx Celebrated for Excellence in Technology at 2025 Best in Biz Awards
globenewswire.com
APLS
Sobi Receives Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
prnewswire.com
APLS
Apolosign Unveils Three Family-Friendly Holiday Gifts as Americans Seek Practical, Heartwarming Tech This Season
globenewswire.com
APLS
Applied Systems Deepens Commitment to Customer Data Intelligence with Epic Dashboards Enhancements and New Administrator Certification Program
globenewswire.com
APLS